| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |